Publicaciones en las que colabora con IRENE BRAVO OSUNA (30)

2022

  1. Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

    Pharmaceutics, Vol. 14, Núm. 7

  2. Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. A safe gdnf and gdnf/bdnf controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: Potential usefulness in degenerative retinal pathologies

    Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-24

  2. Co-delivery of glial cell–derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 566-580

  3. Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 228

  4. Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21

  5. Microparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations

    AAPS Advances in the Pharmaceutical Sciences Series (Springer), pp. 381-407

  6. Thermo-responsive PLGA-PEG-PLGA hydrogels as novel injectable platforms for neuroprotective combined therapies in the treatment of retinal degenerative diseases

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-23

2020

  1. Gelatin nanoparticles-HPMC hybrid system for effective ocular topical administration of antihypertensive agents

    Pharmaceutics, Vol. 12, Núm. 4

  2. Trojan microparticles potential for ophthalmic drug delivery

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 570-582

2019

  1. CHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve

    RSC Drug Discovery Series, Vol. 2019-January, Núm. 66, pp. 164-178

  2. Osmoprotectants in hybrid liposome/HPMC systems as potential glaucoma treatment

    Polymers, Vol. 11, Núm. 6

  3. Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma

    Journal of Controlled Release, Vol. 297, pp. 26-38

2018

  1. Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina

    Advanced Drug Delivery Reviews, Vol. 126, pp. 127-144

  2. Photoreceptor preservation induced by intravitreal controlled delivery of gdnf and gdnf/melatonin in rhodopsin knockout mice

    Molecular Vision, Vol. 24, pp. 733-745

2017

  1. Novel technologies for the delivery of ocular therapeutics in glaucoma

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 181-192

  2. Nueva herramienta educativa bilingüe, de aplicación en el laboratorio: guía gráfica de prácticas de tecnología farmacéutica

    Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de resúmenes XIV FECIES

  3. Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits

    European Journal of Pharmaceutical Sciences, Vol. 103, pp. 19-26

  4. Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site

    Journal of Controlled Release, Vol. 266, pp. 187-197

2016

  1. Ketorolac administration attenuates retinal ganglion cell death after axonal injury

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 3, pp. 1183-1192